Kaytes, Karen

Kaytes, Karen was paid $38K by Medicaid between Dec 2019 and Jul 2022, across 7 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 32% of everything it billed.

33Billing provider infoKAYTES, KAREN
MIDDLETOWN, NY 10940

33aNPI1679059216assigned 07/17/2018

33bProvider typeMedical Physician Assistant

28Total paid$38K

24GClaims351

24DCodes billed7

24AFirst – last monthDec 2019 – Jul 2022

Compared with peers

Next to other Medical Physician Assistant providers in New York

Rank by total paid#15 of 116

Median peer was paid$2K

This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	14	$2K
2020	64	$8K
2021	134	$14K
2022	139	$13K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	32%	93	93	$12K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	107	107	$11K
S9083	Global fee urgent care centers	16%	42	42	$6K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	37	36	$5K
87631		4.8%	13	13	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	4.4%	23	23	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.2%	36	36	$835.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.